University of Minnesota at ObesityWeek 2026
Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website
University of Minnesota brings 18 presentations to ObesityWeek 2026 in National Harbor. Its program centers on treating obesity in children and adolescents, from younger children aged 6 to 12 to teens with type 2 diabetes. Highlights include efficacy and safety results from the SURMOUNT-ADOLESCENTS trial and a randomized trial comparing lifestyle treatment with pharmacotherapy in adolescents.
| Organization | ObesityWeek 2026 Attendance |
|---|---|
University of Minnesota Minneapolis, MN | |
Public land-grant research university in Minneapolis and Saint Paul with a medical school. | Session Fri Nov 13 1:00pm–6:15pm Pediatric Obesity: Comprehensive Care and Practical Strategies for Today's Clinician - Day 1 Practical course for clinicians on pediatric obesity care, combining nutrition, behavior therapy and newer drugs, with case simulations and workflow strategies. Clinical obesity care and professional practiceObesity pharmacotherapy and drug developmentPediatric and adolescent obesityNutrition, diet and food Talk Fri Nov 13 4:30pm–5:15pm Pharmacotherapy Clinical obesity care and professional practiceObesity pharmacotherapy and drug developmentPediatric and adolescent obesityNutrition, diet and food Session Sat Nov 14 8:00am–12:45pm Pediatric Obesity: Comprehensive Care and Practical Strategies for Today's Clinician - Day 2 Interprofessional course on pediatric obesity care, covering nutrition counseling, behavior therapy, newer medicines, special populations and clinic efficiency. Clinical obesity care and professional practiceObesity pharmacotherapy and drug developmentPediatric and adolescent obesityNutrition, diet and food Poster Sat Nov 14 7:30pm–8:30pm Physical Activity and Sedentary Behavior in Youth with Type 2 Diabetes: A Preliminary Investigation Neuroscience of appetite and eating Poster Sat Nov 14 7:30pm–8:30pm Impulsiveness and Hedonics in Individuals With Obesity Who Self-Report Loss of Control Eating Nutrition, diet and food Session Sun Nov 15 8:30am–9:30am From Kids to Older Adults: Should the "Healthy" Use GLP-1s? Debates whether GLP-1 drugs should be used by metabolically healthy children and adults, weighing benefits, growth in youth, nutrition, equity and resource use. Population health and epidemiologyClinical obesity care and professional practicePediatric and adolescent obesityObesity pharmacotherapy and drug development Session Sun Nov 15 12:00pm–1:00pm TOS Clinical Science Section Meeting (TOS members only) - Ethical and Statistical Considerations for Obesity Research in 2026 and Beyond Two experts discuss the ethics of placebo arms in obesity drug trials and statistical designs that limit placebo exposure and handle rescue therapy. Interventional and clinical studies Talk Sun Nov 15 6:10pm–6:15pm Talk Sun Nov 15 6:20pm–6:30pm Session Mon Nov 16 10:00am–11:30am Talk Mon Nov 16 10:50am–11:10am Building a Whole-of-Systems Research Framework to Address Obesity as a Mechanism for Cancer Prevention and Control in Minnesota Population health and epidemiologyChronic disease and obesity complications Poster Mon Nov 16 2:30pm–3:30pm Baseline Characteristics of Treatment-Seeking Adolescents with Obesity in a Self-Weighing Study Clinical obesity care and professional practice Poster Mon Nov 16 2:30pm–3:30pm Beyond BMI: Exploring Similar Trajectories with Divergent Outcomes Among Adolescents with Obesity Pediatric and adolescent obesityPopulation health and epidemiology Poster Mon Nov 16 2:30pm–3:30pm Quality of Life Outcomes in Youth with Type 2 Diabetes Treated with Phentermine/Topiramate Clinical obesity care and professional practice Poster Mon Nov 16 2:30pm–3:30pm Adipose Tissue Change in Adults with Obesity: The Impact of Dietary Interventions Nutrition, diet and food Talk Mon Nov 16 4:15pm–4:30pm Session Mon Nov 16 5:00pm–6:30pm The Wonder Years: Treatment of Obesity in Younger Children, 6-12 Years Reviews research and treatment for obesity in children under 12, including off-label medicines and genetic syndromes, with case examples of combined approaches. Interventional and clinical studiesClinical obesity care and professional practicePolicy and public healthNutrition, diet and foodPediatric and adolescent obesityObesity pharmacotherapy and drug development Talk Mon Nov 16 5:00pm–5:20pm Pharmacologic Treatment of Younger Children: Newer and Off-label Therapies Interventional and clinical studiesClinical obesity care and professional practicePolicy and public healthNutrition, diet and foodPediatric and adolescent obesityObesity pharmacotherapy and drug development |
Find decision makers at University of Minnesota
Tell us what you sell and we’ll find the people at University of Minnesota most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction